Vivos Therapeutics, Inc.
VVOS • NASDAQ
Vivos Therapeutics, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO R. Kirk Huntsman, with a market cap of $17.1M.
CEOR. Kirk Huntsman
Market Cap$17.1M
Medical - Devices
Healthcare
Employees114.0
Websitevivos.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Vivos Therapeutics, Inc.
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.50
Revenue Estimate
$7.1M
Earnings History
Past 12 earnings reports for Vivos Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Q3 2025 | -$0.49Est: -$0.52 | +5.8% | $6.8MEst: $4.7M | +45.0% |  10-Q |
| Aug 19, 2025 | Q2 2025 | -$0.55Est: -$0.38 | -44.7% | $3.8MEst: $3.7M | +3.3% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.45Est: -$0.40 | -12.5% | $3.0MEst: $3.7M | -17.8% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.28Est: -$0.43 | +34.9% | $3.7MEst: $3.9M | -4.9% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.40Est: -$0.70 | +42.9% | $3.9MEst: $4.2M | -7.7% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.60Est: -$1.05 | +42.9% | $4.1MEst: $3.6M | +12.6% | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.63 | — | $3.4M | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$3.05Est: -$1.90 | -60.5% | $3.2MEst: $3.4M | -4.8% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$1.75 | — | $3.3M | — | — |
| Aug 16, 2023 | Q2 2023 | -$4.50Est: -$3.50 | -28.6% | $3.4MEst: $4.2M | -18.2% | 10-Q |
| Jun 8, 2023 | Q1 2023 | -$5.00Est: -$4.50 | -11.1% | $3.9MEst: $4.0M | -3.8% | — |
| Mar 30, 2023 | Q4 2022 | -$5.00Est: -$5.50 | +9.1% | $4.0MEst: $4.6M | -13.2% | — |